Drug-antibody conjugates with anti-HIV activity

Biochemical Pharmacology

Volumn 58, Issue 11, 1999, Pages 1781-1790

  Paulik, Mark ^a   Grieco, Paul ^c   Kim, Chinpal ^a   Maxeiner, Hans Günther ^d   Grunert, Hans Peter ^d   Zeichhardt, Heinz ^d   Morré, Dorothy M ^b   Morré, D James ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AZT; Drug conjugates; Glaucarubolone; Human immunodeficiency virus (HIV); MOLT 4 cells; Peripheral blood mononuclear cells (PBMCs); Quassinoids

Indexed keywords

BREFELDIN A; DRUG ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LENTIVIRINAE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; GLYCOPROTEINS; HIV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNOCONJUGATES; IMMUNODEFICIENCY VIRUS, FELINE; LEUKOCYTES, MONONUCLEAR; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE INHIBITORS; TUMOR CELLS, CULTURED; VIRUS REPLICATION; ZIDOVUDINE;

EID: 0032699350     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00272-5     Document Type: Article

References (37)

1. Morré D.J., Paulik M., Lawrence J.M., Morré D.M. Inhibition by brefeldin A of NADH oxidation activity of rat liver Golgi apparatus accelerated by GDP. FEBS Lett. 346:1994;199-202.
2. Morré D.J., Zeichhardt H., Maxeiner H.G., Grünert H.P., Sawitzky D., Grieco P. Effect of the quassinoids glaucarubolone and simalikalactone D on growth of cells permanently infected with feline and human immunodeficiency viruses and on viral infections. Life Sci. 62:1998;213-219.
3. Owens R.J., Compans R.W. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol. 63:1989;978-982.
4. Stephens E.B., Compans R.W. Assembly of animal viruses at cellular membranes. Annu Rev Microbiol. 42:1988;489-516.
5. Saraste J., Kuismanen E. Pre- and post-Golgi vacuoles operate in the transport of Semliki Forest virus membrane glycoproteins to the cell surface. Cell. 38:1984;535-549.
6. - cells Determination of the first site of budding of progeny virions . Eur J Cell Biol. 33:1984;281-293.
7. Morré D.J., Ovtracht L. Dynamics of the Golgi apparatus Membrane differentiation and membrane flow . Int Rev Cytol Suppl. 5:1977;61-188.
8. Phillips T.R., Talbott R.L., Lamont C., Muir S., Lovelace K., Elder J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J Virol. 64:1990;4605-4613.
9. Japour AJ, Mayers DL, Johnson VA, Kuritzkes DR, Beckett LA, Arduino JM, Lane J, Black RJ, Reichelderfer PS, D'Aquila RT, Crumpacker CS, the RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group, Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother 37: 1095-1101, 1993.
10. Fleck T.J., Grieco P.A. Synthetic studies on quassinoids Total synthesis of (±)-glaucarubolone and (±)-holacanthone . Tetrahedron Lett. 14:1992;1813-1816.
11. Hopp T.P., Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA. 78:1981;3824-3828.
12. Emini E.A., Hughes J.V., Perlow D.S., Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 55:1985;836-839.
13. Jameson B.A., Wolf H. The antigenic index A novel algorithm for predicting antigenic determinants . Comput Appl Biosci. 4:1988;181-186.
14. Morré D.J., Kim C., Paulik M., Morré D.M., Faulk W.P. Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin? J Bioenerg Biomembr. 29:1997;269-280.
15. Morré D.J., Grieco P.A., Morré D.M. Mode of action of the anticancer quassinoids - Inhibition of the plasma membrane NADH oxidase. Life Sci. 63:1998;595-604.
16. Morré D.J. Hormone- and growth factor-stimulated NADH oxidase. J Bioenerg Biomembr. 26:1994;421-433.
17. Whealy M.E., Card J.P., Meade R.P., Robbins A.K., Enquist L.W. Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress. J Virol. 65:1991;1066-1081.
18. Zhou X., Glas R., Momburg F., Hammerling G.J., Jondal M., Ljunggren H.G. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur J Immunol. 23:1993;1796-1801.
19. Kuzushima K., Isobe K., Morishima T., Takatsuki A., Nakashima I. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes. J Immunol. 144:1990;4536-4540.
20. Tucker S.P., Thornton C.L., Wimmer E., Compans R.W. Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol. 67:1993;4274-4282.
21. Sreenivasan V., Ng K.L., Ng M.L. Brefeldin A affects West Nile virus replication in Vero cells but not C6/36 cells. J Virol Methods. 45:1993;1-17.
22. Battini J.L., Danos O., Heard J.M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol. 69:1995;713-719.
23. Ryser H.J., Levy E.M., Mandel R., Di Sciullo G.J. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci USA. 91:1994;4559-4563.
24. Abell B.A., Brown D.T. Sindbis virus membrane fusion is mediated by reduction of glycoprotein disulfide bridges at the cell surface. J Virol. 67:1993;5496-5501.
25. Freedman R.B. Protein disulfide isomerase Multiple roles in the modification of nascent secretory proteins . Cell. 57:1989;1069-1072.
26. Morré D.J., Jacobs E., Sweeting M., de Cabo R., Morré D.M. A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984). Biochim Biophys Acta. 1325:1997;117-125.
27. Chivers P.T., Laboissiere M.C.A., Raines R.T. The CXXC motif Imperatives for the formation of native disulfide bonds in the cell . EMBO J. 15:1996;2659-2667.
28. Bardwell J.C.A., Beckwith J. The bonds that tie Catalyzed disulfide bond formation . Cell. 74:1993;769-771.
29. Morré D.J. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984) at an external site. Biochim Biophys Acta. 1240:1995;201-208.
30. Brightman A.O., Wang J., Miu R.K.M., Sun I.L., Barr R., Crane F.L., Morré D.J. A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane. Biochim Biophys Acta. 1105:1992;109-117.
31. Morré D.J., Chueh P.J., Morré D.M. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA. 92:1995;1831-1835.
32. Bruno M., Brightman A.O., Lawrence J., Werderitsh D., Morré D.M., Morré D.J. Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes. Biochem J. 284:1992;625-628.
33. Morré D.J., Morré D.M. Differential response of the NADH oxidase of plasma membranes of rat liver and hepatoma and HeLa cells to thiol reagents. J Bioenerg Biomembr. 27:1995;137-144.
34. Morré D.J., Wu L.Y., Morré D.M. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes. Biochim Biophys Acta. 1240:1995;11-17.
35. Sun I.L., Sun E., Crane F.L., Morré D.J., Lundgren A., Löw H. Requirement for coenzyme Q in plasma membrane electron transport. Proc Natl Acad Sci USA. 89:1992;11126-11130.
36. Morré D.J., Morré D.M., Stevenson J., MacKellar W., McClure D. HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinity. Biochim Biophys Acta. 1244:1995;133-140.
37. Kim C., MacKellar W.C., Cho N., Byrn S.R., Morré D.J. Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients. Biochim Biophys Acta. 1324:1997;171-181.